About Us | Our History
Building on 40 Years of Medical Device Excellence
In 1981, a group of physicists from Georgia Institute of Technology decided to develop and market radiological pharmaceuticals and devices to fight cancer. They founded Theragenics to advance that mission.
Over the years, Theragenics grew to become a global leader in radioactive brachytherapy seeds designed to treat prostate and other cancers. Its TheraSeed® and AgX100® implants have been used to treat hundreds of thousands of patients worldwide.
Our diversified portfolio now includes industry leading vascular surgery and interventional radiology devices, as well as products for interventional cardiology. Our capabilities have also broadened to include device design and development services. Our commitment to providing you with life-changing medical solutions remains the same.